社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
CokeNBeer
IP属地：未知
+关注
帖子 · 142
帖子 · 142
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
CokeNBeer
CokeNBeer
·
2021-12-22
😊
Cathie Wood Loaded Up On These 2 Cryptocurrency-Related Stocks On Tuesday
Cathie Wood'sArk Investment Management on Monday further raised its exposure in cryptocurrency-relat
Cathie Wood Loaded Up On These 2 Cryptocurrency-Related Stocks On Tuesday
看
1,241
回复
2
点赞
3
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-21
Need Santa help. 😊
Monday is an ugly one for the stock market.Is pre-Christmas fall a chance to buy the dip?
The folks at Fundstrat Global Advisors have some good news and bad news for Wall Street, as investor
Monday is an ugly one for the stock market.Is pre-Christmas fall a chance to buy the dip?
看
941
回复
1
点赞
2
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-20
Now?
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
看
1,212
回复
评论
点赞
2
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-20
Yeah
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
看
1,773
回复
评论
点赞
3
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-19
👍🏼
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade
The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade
看
1,409
回复
1
点赞
7
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-18
Low trading volume for the rest of the year.
看
1,299
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-18
Hello! Good Morning!
EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%
EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown
EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%
看
1,570
回复
1
点赞
8
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-17
Is the fund going up?
Tesla: Cathie Wood's Actions Speak Louder Than Words
Summary Ark Invest continues to sell shares of the EV company. Weight in the top fund now is below
Tesla: Cathie Wood's Actions Speak Louder Than Words
看
1,170
回复
2
点赞
2
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-16
We
Fed heads for the exits despite Omicron. Who will follow?
(Reuters) - The U.S. Federal Reserve didn't beat around the bush on Wednesday when it signaled that
Fed heads for the exits despite Omicron. Who will follow?
看
975
回复
1
点赞
4
编组 21备份 2
分享
举报
CokeNBeer
CokeNBeer
·
2021-12-14
Go up pls
非常抱歉，此主贴已删除
看
1,419
回复
1
点赞
7
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581722811684208","uuid":"3581722811684208","gmtCreate":1618646850910,"gmtModify":1621476481988,"name":"CokeNBeer","pinyin":"cokenbeer","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":378,"tweetSize":142,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691851142,"gmtCreate":1640171513670,"gmtModify":1640171995835,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"😊","listText":"😊","text":"😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691851142","repostId":"1113551998","repostType":4,"repost":{"id":"1113551998","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640166938,"share":"https://www.laohu8.com/m/news/1113551998?lang=&edition=full","pubTime":"2021-12-22 17:55","market":"us","language":"en","title":"Cathie Wood Loaded Up On These 2 Cryptocurrency-Related Stocks On Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1113551998","media":"Benzinga","summary":"Cathie Wood'sArk Investment Management on Monday further raised its exposure in cryptocurrency-relat","content":"<p><b>Cathie Wood'sArk Investment Management</b> on Monday further raised its exposure in cryptocurrency-related stocks <b>Robinhood Markets Inc</b> and <b>Coinbase Global Inc</b>.</p>\n<p>The popular money manager bought 181,717 shares — estimated to be worth $3.44 million — in Robinhood, a financial platform that deals in stocks and cryptocurrencies.</p>\n<p>Robinhood stock closed 4.99% higher in the regular session on Tuesday at $18.93 a share. The stock is down 45.6% since going public in July.</p>\n<p>In a first, Robinhood acquired <b>Cove Markets</b>, a cross-exchange trading platform last week as it prepares to roll out cryptocurrency wallets.</p>\n<p>The wallets would allow Robinhood users to deposit or withdraw cryptocurrencies like <b>Bitcoin</b>,<b>Ethereum</b> and <b>Dogecoin</b>.</p>\n<p>The popular zero-commission trading app also said it is adding a cryptocurrency gifting feature for users, which would be operational from Wednesday.</p>\n<p>The money managing firm owns shares in Robinhood via three ETFs — the <b>ArkInnovation ETF</b></p>\n<p>ARKK, the <b>Ark Fintech Innovation ETF</b> and the <b>Ark Next Generation Internet ETF</b>.</p>\n<p>The three ETFs held 20.2 million shares — worth $364.8 million — in Robinhood, prior to Tuesday’s trade.</p>\n<p>Ark Invest also snapped up 23,414 shares — estimated to be worth $5.79 million — in cryptocurrency exchange desk Coinbase.</p>\n<p>Coinbase shares closed 4.05% higher at $247.69 a share on Tuesday. The stock is down 24.5% so far this year.</p>\n<p><b>Coinbase</b> CEO <b>Brian Armstrong</b> told investors in November that the company is focused on long-term growth instead of a quarter-to-quarter investment as it grows the cryptocurrency economy.</p>\n<p>Ark Invest has mostly been piling shares in Coinbase since its direct listing on NASDAQ in April, while occasionally booking minor profits.</p>\n<p>The popular managing firm held 4.9 million shares — worth $1.18 billion — in Coinbase via three ETFs — ARKK, ARKF and ARKW — prior to Wednesday's trades.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loaded Up On These 2 Cryptocurrency-Related Stocks On Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loaded Up On These 2 Cryptocurrency-Related Stocks On Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-22 17:55</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood'sArk Investment Management</b> on Monday further raised its exposure in cryptocurrency-related stocks <b>Robinhood Markets Inc</b> and <b>Coinbase Global Inc</b>.</p>\n<p>The popular money manager bought 181,717 shares — estimated to be worth $3.44 million — in Robinhood, a financial platform that deals in stocks and cryptocurrencies.</p>\n<p>Robinhood stock closed 4.99% higher in the regular session on Tuesday at $18.93 a share. The stock is down 45.6% since going public in July.</p>\n<p>In a first, Robinhood acquired <b>Cove Markets</b>, a cross-exchange trading platform last week as it prepares to roll out cryptocurrency wallets.</p>\n<p>The wallets would allow Robinhood users to deposit or withdraw cryptocurrencies like <b>Bitcoin</b>,<b>Ethereum</b> and <b>Dogecoin</b>.</p>\n<p>The popular zero-commission trading app also said it is adding a cryptocurrency gifting feature for users, which would be operational from Wednesday.</p>\n<p>The money managing firm owns shares in Robinhood via three ETFs — the <b>ArkInnovation ETF</b></p>\n<p>ARKK, the <b>Ark Fintech Innovation ETF</b> and the <b>Ark Next Generation Internet ETF</b>.</p>\n<p>The three ETFs held 20.2 million shares — worth $364.8 million — in Robinhood, prior to Tuesday’s trade.</p>\n<p>Ark Invest also snapped up 23,414 shares — estimated to be worth $5.79 million — in cryptocurrency exchange desk Coinbase.</p>\n<p>Coinbase shares closed 4.05% higher at $247.69 a share on Tuesday. The stock is down 24.5% so far this year.</p>\n<p><b>Coinbase</b> CEO <b>Brian Armstrong</b> told investors in November that the company is focused on long-term growth instead of a quarter-to-quarter investment as it grows the cryptocurrency economy.</p>\n<p>Ark Invest has mostly been piling shares in Coinbase since its direct listing on NASDAQ in April, while occasionally booking minor profits.</p>\n<p>The popular managing firm held 4.9 million shares — worth $1.18 billion — in Coinbase via three ETFs — ARKK, ARKF and ARKW — prior to Wednesday's trades.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","HOOD":"Robinhood"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113551998","content_text":"Cathie Wood'sArk Investment Management on Monday further raised its exposure in cryptocurrency-related stocks Robinhood Markets Inc and Coinbase Global Inc.\nThe popular money manager bought 181,717 shares — estimated to be worth $3.44 million — in Robinhood, a financial platform that deals in stocks and cryptocurrencies.\nRobinhood stock closed 4.99% higher in the regular session on Tuesday at $18.93 a share. The stock is down 45.6% since going public in July.\nIn a first, Robinhood acquired Cove Markets, a cross-exchange trading platform last week as it prepares to roll out cryptocurrency wallets.\nThe wallets would allow Robinhood users to deposit or withdraw cryptocurrencies like Bitcoin,Ethereum and Dogecoin.\nThe popular zero-commission trading app also said it is adding a cryptocurrency gifting feature for users, which would be operational from Wednesday.\nThe money managing firm owns shares in Robinhood via three ETFs — the ArkInnovation ETF\nARKK, the Ark Fintech Innovation ETF and the Ark Next Generation Internet ETF.\nThe three ETFs held 20.2 million shares — worth $364.8 million — in Robinhood, prior to Tuesday’s trade.\nArk Invest also snapped up 23,414 shares — estimated to be worth $5.79 million — in cryptocurrency exchange desk Coinbase.\nCoinbase shares closed 4.05% higher at $247.69 a share on Tuesday. The stock is down 24.5% so far this year.\nCoinbase CEO Brian Armstrong told investors in November that the company is focused on long-term growth instead of a quarter-to-quarter investment as it grows the cryptocurrency economy.\nArk Invest has mostly been piling shares in Coinbase since its direct listing on NASDAQ in April, while occasionally booking minor profits.\nThe popular managing firm held 4.9 million shares — worth $1.18 billion — in Coinbase via three ETFs — ARKK, ARKF and ARKW — prior to Wednesday's trades.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693421347,"gmtCreate":1640066353690,"gmtModify":1640066353987,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Need Santa help. 😊","listText":"Need Santa help. 😊","text":"Need Santa help. 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693421347","repostId":"2193132324","repostType":4,"repost":{"id":"2193132324","kind":"highlight","pubTimestamp":1640054988,"share":"https://www.laohu8.com/m/news/2193132324?lang=&edition=full","pubTime":"2021-12-21 10:49","market":"us","language":"en","title":"Monday is an ugly one for the stock market.Is pre-Christmas fall a chance to buy the dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2193132324","media":"MarketWatch","summary":"The folks at Fundstrat Global Advisors have some good news and bad news for Wall Street, as investor","content":"<p>The folks at Fundstrat Global Advisors have some good news and bad news for Wall Street, as investors and traders face the penultimate week of action in 2021: Monday's stock slump is a precursor to more pain, but things could get better for the bulls closer to Christmas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3c84cc3d0cddc33dcb46b3248e64deb0\" tg-width=\"700\" tg-height=\"492\" referrerpolicy=\"no-referrer\"><span>There may still be a Christmas treat in store for investors. AFP/Getty Images</span></p>\n<p>That is the takeaway from a report on the technical setup for the markets after the Dow Jones Industrial Average , the S&P 500 and the Nasdaq Composite all notched their third consecutive losses Monday, with the decline for the technology-heavy Nasdaq bringing the benchmark to its lowest level since Oct. 15 and putting it nearly 7% below its Nov. 19 record close.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/caec11e4f6223c1eec4544a3d10acd39\" tg-width=\"700\" tg-height=\"390\" referrerpolicy=\"no-referrer\"><span>via Fundstrat Global</span></p>\n<p>\"Monday's break of 4,600 has resulted in further near-term deterioration, but also suggests additional selling lies in store for SPX ahead of any low later this week,\" wrote Fundstrat's Mark Newton.</p>\n<p>Newton said that a deterioration in so-called FAANG stocks -- the group consisting of <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a> Inc. (FB) (formerly known as Facbook Inc.), Apple Inc., Amazon.com, Netflix Inc. and Google holding company Alphabet Inc.(GOOGL) -- is pointing to additional declines in stocks, as gauged by the Invesco QQQ Trust and NY-FANG Composite Index.</p>\n<p>\"QQQ break of 383 from last week keeps the near-term trend negative here also, and should allow for extensions down to 371 before rallies into year-end get under way,\" the Fundstrat note said. The popular QQQ, which represents the largest companies in the Nasdaq Composite, closed Monday at 380.69, and is down 3.3% in the month to date but up 21.3% in 2021 thus far.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4c75da6c330eaecb6f413b03881b780b\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>via Fundstrat Global</span></p>\n<p>Meanwhile, Newson wrote that the NY-FANG Composite index, along with the addition of Microsoft Corp., has neared \"'Make-or-Break' levels from a mild uptrend from Spring 2021 lows.\"</p>\n<p>Newton said he is expecting the downturn to provide opportunities for investors, despite technical indicators pointing to further selling in the coming days.</p>\n<p>\"Sentiment has turned quite negative near-term, and bearish sentiment combined with bullish seasonality looks to be an effective 1-2 combo to buy dips ahead of Christmas,\" he wrote.</p>\n<p>Newton said that a confluence of factors suggests that the atmosphere could improve by the end of the week, but cautioned that if trend lines are broken, \"one will need to hold out for some evidence of stabilization.\"</p>\n<p>Fundstrat also remains bullish on the so-called Santa Claus Rally period, which is technically the final five trading days of a calendar year and the first two sessions in January.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Monday is an ugly one for the stock market.Is pre-Christmas fall a chance to buy the dip?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMonday is an ugly one for the stock market.Is pre-Christmas fall a chance to buy the dip?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 10:49 GMT+8 <a href=https://www.marketwatch.com/story/s-p-500-faces-a-further-skid-before-bottoming-but-pre-christmas-fall-may-offer-chance-to-buy-the-dip-says-fundstrat-11640051820?mod=hp_LATEST><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The folks at Fundstrat Global Advisors have some good news and bad news for Wall Street, as investors and traders face the penultimate week of action in 2021: Monday's stock slump is a precursor to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/s-p-500-faces-a-further-skid-before-bottoming-but-pre-christmas-fall-may-offer-chance-to-buy-the-dip-says-fundstrat-11640051820?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/s-p-500-faces-a-further-skid-before-bottoming-but-pre-christmas-fall-may-offer-chance-to-buy-the-dip-says-fundstrat-11640051820?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193132324","content_text":"The folks at Fundstrat Global Advisors have some good news and bad news for Wall Street, as investors and traders face the penultimate week of action in 2021: Monday's stock slump is a precursor to more pain, but things could get better for the bulls closer to Christmas.\nThere may still be a Christmas treat in store for investors. AFP/Getty Images\nThat is the takeaway from a report on the technical setup for the markets after the Dow Jones Industrial Average , the S&P 500 and the Nasdaq Composite all notched their third consecutive losses Monday, with the decline for the technology-heavy Nasdaq bringing the benchmark to its lowest level since Oct. 15 and putting it nearly 7% below its Nov. 19 record close.\nvia Fundstrat Global\n\"Monday's break of 4,600 has resulted in further near-term deterioration, but also suggests additional selling lies in store for SPX ahead of any low later this week,\" wrote Fundstrat's Mark Newton.\nNewton said that a deterioration in so-called FAANG stocks -- the group consisting of Meta Platforms Inc. (FB) (formerly known as Facbook Inc.), Apple Inc., Amazon.com, Netflix Inc. and Google holding company Alphabet Inc.(GOOGL) -- is pointing to additional declines in stocks, as gauged by the Invesco QQQ Trust and NY-FANG Composite Index.\n\"QQQ break of 383 from last week keeps the near-term trend negative here also, and should allow for extensions down to 371 before rallies into year-end get under way,\" the Fundstrat note said. The popular QQQ, which represents the largest companies in the Nasdaq Composite, closed Monday at 380.69, and is down 3.3% in the month to date but up 21.3% in 2021 thus far.\nvia Fundstrat Global\nMeanwhile, Newson wrote that the NY-FANG Composite index, along with the addition of Microsoft Corp., has neared \"'Make-or-Break' levels from a mild uptrend from Spring 2021 lows.\"\nNewton said he is expecting the downturn to provide opportunities for investors, despite technical indicators pointing to further selling in the coming days.\n\"Sentiment has turned quite negative near-term, and bearish sentiment combined with bullish seasonality looks to be an effective 1-2 combo to buy dips ahead of Christmas,\" he wrote.\nNewton said that a confluence of factors suggests that the atmosphere could improve by the end of the week, but cautioned that if trend lines are broken, \"one will need to hold out for some evidence of stabilization.\"\nFundstrat also remains bullish on the so-called Santa Claus Rally period, which is technically the final five trading days of a calendar year and the first two sessions in January.","news_type":1},"isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693151046,"gmtCreate":1639990915980,"gmtModify":1639990916260,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Now?","listText":"Now?","text":"Now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693151046","repostId":"1155454954","repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b> on Friday bought 26,126 shares — estimated to be worth $163,026 — in <b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund <b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.</p>\n<p>The company went public earlier this year in a SPAC merger with <b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of <b>Butterfly Network Inc</b>, a company backed by <b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b> on Friday bought 26,126 shares — estimated to be worth $163,026 — in <b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund <b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.</p>\n<p>The company went public earlier this year in a SPAC merger with <b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of <b>Butterfly Network Inc</b>, a company backed by <b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693153769,"gmtCreate":1639990899970,"gmtModify":1639990900299,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Yeah ","listText":"Yeah ","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693153769","repostId":"1155454954","repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b> on Friday bought 26,126 shares — estimated to be worth $163,026 — in <b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund <b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.</p>\n<p>The company went public earlier this year in a SPAC merger with <b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of <b>Butterfly Network Inc</b>, a company backed by <b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b> on Friday bought 26,126 shares — estimated to be worth $163,026 — in <b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund <b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.</p>\n<p>The company went public earlier this year in a SPAC merger with <b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of <b>Butterfly Network Inc</b>, a company backed by <b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699786810,"gmtCreate":1639897340763,"gmtModify":1639897341068,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"👍🏼","listText":"👍🏼","text":"👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699786810","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p>\n<p>Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p>\n<p>Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p>\n<p><a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p>\n<p>Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p>\n<p>Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p>\n<p>Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p>\n<p>Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 11:21 GMT+8 <a href=https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699242049,"gmtCreate":1639823218420,"gmtModify":1639823218728,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Low trading volume for the rest of the year. ","listText":"Low trading volume for the rest of the year. ","text":"Low trading volume for the rest of the year.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699242049","isVote":1,"tweetType":1,"viewCount":1299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699632770,"gmtCreate":1639790098897,"gmtModify":1639790099171,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Hello! Good Morning!","listText":"Hello! Good Morning!","text":"Hello! Good Morning!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699632770","repostId":"1113440959","repostType":4,"repost":{"id":"1113440959","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752802,"share":"https://www.laohu8.com/m/news/1113440959?lang=&edition=full","pubTime":"2021-12-17 22:53","market":"us","language":"en","title":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113440959","media":"Tiger Newspress","summary":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown","content":"<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown Motors sliding 6% and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown Motors sliding 6% and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113440959","content_text":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown Motors sliding 6% and General Motors sliding 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690762329,"gmtCreate":1639710157758,"gmtModify":1639710158072,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Is the fund going up?","listText":"Is the fund going up?","text":"Is the fund going up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690762329","repostId":"1141867982","repostType":4,"repost":{"id":"1141867982","kind":"news","pubTimestamp":1639708874,"share":"https://www.laohu8.com/m/news/1141867982?lang=&edition=full","pubTime":"2021-12-17 10:41","market":"us","language":"en","title":"Tesla: Cathie Wood's Actions Speak Louder Than Words","url":"https://stock-news.laohu8.com/highlight/detail?id=1141867982","media":"Seeking Alpha","summary":"Summary\n\nArk Invest continues to sell shares of the EV company.\nWeight in the top fund now is below ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Ark Invest continues to sell shares of the EV company.</li>\n <li>Weight in the top fund now is below 7.75%.</li>\n <li>Lack of purchases for undervalued stock is telling.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b7aab2de2ec892bafc5a0ef6e0335fec\" tg-width=\"1536\" tg-height=\"1025\" width=\"100%\" height=\"auto\"><span>Justin Sullivan/Getty Images News</span></p>\n<p>When it comes to electric vehicle maker Tesla (TSLA), one of the biggest and most vocal bulls in recent years has been Cathie Wood. The leader of Ark Investment Management has been all over various financial media preaching her love for the company and its stock. However, despite all the positive sentiment, her firm has been selling Tesla shares in massive amounts recently.</p>\n<p>As those who have followed my Tesla coverage here know, I've been tracking Ark Invest's daily Tesla holdings since late March 2020. The stock is held primarily in three of Ark's active ETFs - the Innovation ETF (ARKK), the Autonomous Technology and Robotics ETF (ARKQ), and the Next Generation Internet ETF (ARKW). Recently, Ark Invest launched a Transparency ETF (CTRU) that holds Tesla, but this is an index-based ETF that follows a specific index, and it is very small currently. The Transparency ETF doesn't make large daily allocation moves like the Active ETFs do, so it's not really vital to the argument here today.</p>\n<p>For its Active ETFs, Ark Invest sends out a daily e-mail that details the firm's allocation trades. These are specific buys or sells in an individual name to change the stock's weighting in one of the six Active ETFs. There are also position changes daily due to inflows or redemptions, but these are not shown in the e-mail. To see those changes, you have to track holdings daily like I have. The graphic below shows Wednesday's allocation changes for ARKK.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fb55e624d01be71b7bccdfe2b1836d3f\" tg-width=\"640\" tg-height=\"525\" width=\"100%\" height=\"auto\"><span>Source: Ark Invest Daily Trades E-mail</span></p>\n<p>ARKK is known as the Ark Invest \"mothership,\" since it's the firm's flagship fund and contains about 52% of the firm's total assets under management. Wednesday's Tesla sale in this ETF was its 12th in the past 19 trading days, and Ark Invest also sold another 22,579 shares on Wednesday in the other two Active ETFs that hold the stock. This continues a selling pattern that started in late July, and Ark Invest hasn't bought Tesla on an allocation basis in any of the three funds since July 7.</p>\n<p>Before counting any changes due to inflows and redemptions on Wednesday, the three Tesla sales on Wednesday would put total Tesla holdings in the Active ETFs at about 1.9 million shares. At their individual peaks, these ETFs combined to hold more than 5.575 million shares, so this is a dramatic shift in sentiment for the firm (the individual daily combined total peak for the three ETFs was more than 5.515 million shares).</p>\n<p>The massive Tesla sales recently are especially strange when you consider last week's CNBC appearance. Cathie Wood was on the network saying how Tesla is undervalued, and she reiterated her $3,000 base case price target on the stock. That was when shares were around $1,050, and yet she sold shares that day and has continued since, despite Tesla shares falling under $930 during Wednesday's trade before rebounding with the market after the Fed decision.</p>\n<p>Now there will be defenders of Cathie Wood talking about position limits in individual names. Well, Ark Invest actually removed these limitsearlier this year, which previously allowed its ETFs to hold up to 30% in any one particular name. As the chart below will show, Tesla never had a daily ending weight of more than 13% in ARKK, so it's not like shares were ever anywhere near this limit anyway. Cathie Wood has a \"self-imposed restriction\" that prevents any allocation buy any stocks that are over 10% in a fund, but there is no set guideline on when she has to sell any names.</p>\n<p>I bring up these percentages because it has to do with Ark's Tesla sales. There will be those saying Cathie sold due to those limits, but that's a false theory. Yes, Tesla shares have certainly rallied in recent years, but when you have a $3,000 price target on the stock, why are you selling under $1,000 currently? Take a look at the chart below, which shows Tesla's weight in ARKK over the past 420 trading days.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/428535a6d7a7e5ffe7a9d198bb5ba675\" tg-width=\"640\" tg-height=\"357\" width=\"100%\" height=\"auto\"><span>Last data point on chart is for weighting as of 12/15. Source: ARKK website tracked daily</span></p>\n<p>Tesla was a 7.73% weight in the flagship fund as of Wednesday. I'll also point out that until last week, Tesla had not been under 8.50% during my tracking period, yet Cathie Wood continues to sell shares even with Tesla's weight at its lowest point in at least 21 months. Previously, when Tesla got back below 10.00%, Ark Invest was usually quick to buy shares again. I will point out that over the past couple of months, about 860,000 shares of her reduced Tesla position has been due to redemptions in her funds as they have crashed from their all-time highs.</p>\n<p>In the end, Cathie Wood's actions regarding Tesla are quite contrary to the statements she has made. The fund manager on Wednesday continued to sell shares in the EV maker, despite it already being at its lowest weight in her flagship fund in more than 400 trading days. Across the three active Ark Invest ETFs, the total holding of shares has come down by nearly two-thirds, although a little less than a quarter of that decline has been due to redemptions. It was only last week that she called Tesla undervalued and reiterated a $3,000 price target, but her recent trading history tells a much different story.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla: Cathie Wood's Actions Speak Louder Than Words</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla: Cathie Wood's Actions Speak Louder Than Words\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 10:41 GMT+8 <a href=https://seekingalpha.com/article/4475631-tesla-cathie-wood-share-sales><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nArk Invest continues to sell shares of the EV company.\nWeight in the top fund now is below 7.75%.\nLack of purchases for undervalued stock is telling.\n\nJustin Sullivan/Getty Images News\nWhen ...</p>\n\n<a href=\"https://seekingalpha.com/article/4475631-tesla-cathie-wood-share-sales\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","ARKK":"ARK Innovation ETF","TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4475631-tesla-cathie-wood-share-sales","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141867982","content_text":"Summary\n\nArk Invest continues to sell shares of the EV company.\nWeight in the top fund now is below 7.75%.\nLack of purchases for undervalued stock is telling.\n\nJustin Sullivan/Getty Images News\nWhen it comes to electric vehicle maker Tesla (TSLA), one of the biggest and most vocal bulls in recent years has been Cathie Wood. The leader of Ark Investment Management has been all over various financial media preaching her love for the company and its stock. However, despite all the positive sentiment, her firm has been selling Tesla shares in massive amounts recently.\nAs those who have followed my Tesla coverage here know, I've been tracking Ark Invest's daily Tesla holdings since late March 2020. The stock is held primarily in three of Ark's active ETFs - the Innovation ETF (ARKK), the Autonomous Technology and Robotics ETF (ARKQ), and the Next Generation Internet ETF (ARKW). Recently, Ark Invest launched a Transparency ETF (CTRU) that holds Tesla, but this is an index-based ETF that follows a specific index, and it is very small currently. The Transparency ETF doesn't make large daily allocation moves like the Active ETFs do, so it's not really vital to the argument here today.\nFor its Active ETFs, Ark Invest sends out a daily e-mail that details the firm's allocation trades. These are specific buys or sells in an individual name to change the stock's weighting in one of the six Active ETFs. There are also position changes daily due to inflows or redemptions, but these are not shown in the e-mail. To see those changes, you have to track holdings daily like I have. The graphic below shows Wednesday's allocation changes for ARKK.\nSource: Ark Invest Daily Trades E-mail\nARKK is known as the Ark Invest \"mothership,\" since it's the firm's flagship fund and contains about 52% of the firm's total assets under management. Wednesday's Tesla sale in this ETF was its 12th in the past 19 trading days, and Ark Invest also sold another 22,579 shares on Wednesday in the other two Active ETFs that hold the stock. This continues a selling pattern that started in late July, and Ark Invest hasn't bought Tesla on an allocation basis in any of the three funds since July 7.\nBefore counting any changes due to inflows and redemptions on Wednesday, the three Tesla sales on Wednesday would put total Tesla holdings in the Active ETFs at about 1.9 million shares. At their individual peaks, these ETFs combined to hold more than 5.575 million shares, so this is a dramatic shift in sentiment for the firm (the individual daily combined total peak for the three ETFs was more than 5.515 million shares).\nThe massive Tesla sales recently are especially strange when you consider last week's CNBC appearance. Cathie Wood was on the network saying how Tesla is undervalued, and she reiterated her $3,000 base case price target on the stock. That was when shares were around $1,050, and yet she sold shares that day and has continued since, despite Tesla shares falling under $930 during Wednesday's trade before rebounding with the market after the Fed decision.\nNow there will be defenders of Cathie Wood talking about position limits in individual names. Well, Ark Invest actually removed these limitsearlier this year, which previously allowed its ETFs to hold up to 30% in any one particular name. As the chart below will show, Tesla never had a daily ending weight of more than 13% in ARKK, so it's not like shares were ever anywhere near this limit anyway. Cathie Wood has a \"self-imposed restriction\" that prevents any allocation buy any stocks that are over 10% in a fund, but there is no set guideline on when she has to sell any names.\nI bring up these percentages because it has to do with Ark's Tesla sales. There will be those saying Cathie sold due to those limits, but that's a false theory. Yes, Tesla shares have certainly rallied in recent years, but when you have a $3,000 price target on the stock, why are you selling under $1,000 currently? Take a look at the chart below, which shows Tesla's weight in ARKK over the past 420 trading days.\nLast data point on chart is for weighting as of 12/15. Source: ARKK website tracked daily\nTesla was a 7.73% weight in the flagship fund as of Wednesday. I'll also point out that until last week, Tesla had not been under 8.50% during my tracking period, yet Cathie Wood continues to sell shares even with Tesla's weight at its lowest point in at least 21 months. Previously, when Tesla got back below 10.00%, Ark Invest was usually quick to buy shares again. I will point out that over the past couple of months, about 860,000 shares of her reduced Tesla position has been due to redemptions in her funds as they have crashed from their all-time highs.\nIn the end, Cathie Wood's actions regarding Tesla are quite contrary to the statements she has made. The fund manager on Wednesday continued to sell shares in the EV maker, despite it already being at its lowest weight in her flagship fund in more than 400 trading days. Across the three active Ark Invest ETFs, the total holding of shares has come down by nearly two-thirds, although a little less than a quarter of that decline has been due to redemptions. It was only last week that she called Tesla undervalued and reiterated a $3,000 price target, but her recent trading history tells a much different story.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690321527,"gmtCreate":1639638613042,"gmtModify":1639638731870,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"We ","listText":"We ","text":"We","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690321527","repostId":"1143095001","repostType":4,"repost":{"id":"1143095001","kind":"news","pubTimestamp":1639635187,"share":"https://www.laohu8.com/m/news/1143095001?lang=&edition=full","pubTime":"2021-12-16 14:13","market":"us","language":"en","title":"Fed heads for the exits despite Omicron. Who will follow?","url":"https://stock-news.laohu8.com/highlight/detail?id=1143095001","media":"Reuters","summary":"(Reuters) - The U.S. Federal Reserve didn't beat around the bush on Wednesday when it signaled that ","content":"<p>(Reuters) - The U.S. Federal Reserve didn't beat around the bush on Wednesday when it signaled that raging inflation is its biggest risk and not the potential economic damage from the fast-spreading Omicron variant.</p>\n<p>The Fed doubled the pace at which it will reduce its bond purchases, while new forecasts from policymakers signaled as many as three interest rate increases next year. Chair Jerome Powell then waxed enthusiastically about the strength of the U.S. job market.</p>\n<p>\"The economy no longer needs increasing amounts of policy support,\" Powell told a news conference. \"In my view, we are making rapid progress toward maximum employment.\"</p>\n<p>Whether any of the Fed's peers are ready to follow its lead, however, will become clear in the next 24 hours with a rapid-fire succession of meetings by the Bank of England, European Central Bank and the Bank of Japan.</p>\n<p>Of the three, however, only the BoE is likely to take more than a baby step in trimming the monumental support provided to its economy through the pandemic. That could set the stage for a choppy 2022 with a Fed determined to end its asset purchases as fast as possible and kick off interest rates soon after, while others will be more hesitant to shift so decisively in that direction.</p>\n<p>The BoE could become the first of the major central banks to raise interest rates at Thursday's policy meeting, but the United Kingdom is also where friction between Omicron and way-over-target inflation is playing out most vividly.</p>\n<p>UK daily coronavirus infections are now at their highest since the earliest days of the pandemic, forcing Prime Minister Boris Johnson this week to join with opposition lawmakers in imposing new restrictions.</p>\n<p>On the other hand, shocking data on Wednesday showed consumer price inflation at a decade-high rate and bets in financial markets on a December rate hike jumped to 60% from about a third.</p>\n<p>\"There is now the real risk of inflation becoming entrenched – especially considering the signs of second-round effects in terms of rising wages, supported by a strong labour market – but this is balanced against the threat to the economic recovery from the new Omicron variant,\" said Ellie Henderson, an economist at bank Investec.</p>\n<p>Investors and economists are not expecting anything nearly as bold this week from either the ECB or BOJ.</p>\n<p>The ECB is expected to be among the last to tighten policy, and the current unusually vibrant debate is focused on whether to dial back an exceptionally generous stimulus scheme just a notch. The caution is easy to understand. The bank has undershot its inflation target for most of the past decade, so it would rather move too late than too early, fearing that a misguided policy tweak could unravel years of work.</p>\n<p>The euro zone's recovery is also trailing others. The bloc is just getting back to its pre-pandemic size and the job market could take another two years to recover. Debt levels are also at record highs, particularly in the bloc's south, so any big retreat could widen the spread between German and Italian debt, raising questions about the sustainability of these debt levels.</p>\n<p>Given that the risk of moving too quick appears to far outweigh the risk of moving too slow, the ECB is likely to take only the smallest step towards removing extraordinary stimulus this week and will signal copious support, including thorough record low rates, at least through next year.</p>\n<p>In Japan, the consumer-level inflation that is tearing through other parts of the globe remains largely absent. As such, only a marginal reduction in corporate asset purchases is under discussion at Friday's BOJ meeting.</p>\n<p>Even if the others are not hard on the Fed's heels, Powell and the Fed appear to have set the agenda for a tumultuous 2022 as central bankers chart their ways to the exits, albeit at dramatically different paces.</p>\n<p>\"You saw it in his congressional remarks that were more about tightening sooner than it was about worrying about the health of the global economy,\" said Vincent Reinhart, chief economist for Dreyfuss & Mellon. The Fed and other central banks are \"conveying a sense that they are heading for the exits. Modern central banking is much about managing expectations and they do not want to be seen as behind the curve.\"</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed heads for the exits despite Omicron. Who will follow?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed heads for the exits despite Omicron. Who will follow?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 14:13 GMT+8 <a href=https://finance.yahoo.com/news/fed-heads-exits-despite-omicron-060632193.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The U.S. Federal Reserve didn't beat around the bush on Wednesday when it signaled that raging inflation is its biggest risk and not the potential economic damage from the fast-spreading ...</p>\n\n<a href=\"https://finance.yahoo.com/news/fed-heads-exits-despite-omicron-060632193.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/fed-heads-exits-despite-omicron-060632193.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143095001","content_text":"(Reuters) - The U.S. Federal Reserve didn't beat around the bush on Wednesday when it signaled that raging inflation is its biggest risk and not the potential economic damage from the fast-spreading Omicron variant.\nThe Fed doubled the pace at which it will reduce its bond purchases, while new forecasts from policymakers signaled as many as three interest rate increases next year. Chair Jerome Powell then waxed enthusiastically about the strength of the U.S. job market.\n\"The economy no longer needs increasing amounts of policy support,\" Powell told a news conference. \"In my view, we are making rapid progress toward maximum employment.\"\nWhether any of the Fed's peers are ready to follow its lead, however, will become clear in the next 24 hours with a rapid-fire succession of meetings by the Bank of England, European Central Bank and the Bank of Japan.\nOf the three, however, only the BoE is likely to take more than a baby step in trimming the monumental support provided to its economy through the pandemic. That could set the stage for a choppy 2022 with a Fed determined to end its asset purchases as fast as possible and kick off interest rates soon after, while others will be more hesitant to shift so decisively in that direction.\nThe BoE could become the first of the major central banks to raise interest rates at Thursday's policy meeting, but the United Kingdom is also where friction between Omicron and way-over-target inflation is playing out most vividly.\nUK daily coronavirus infections are now at their highest since the earliest days of the pandemic, forcing Prime Minister Boris Johnson this week to join with opposition lawmakers in imposing new restrictions.\nOn the other hand, shocking data on Wednesday showed consumer price inflation at a decade-high rate and bets in financial markets on a December rate hike jumped to 60% from about a third.\n\"There is now the real risk of inflation becoming entrenched – especially considering the signs of second-round effects in terms of rising wages, supported by a strong labour market – but this is balanced against the threat to the economic recovery from the new Omicron variant,\" said Ellie Henderson, an economist at bank Investec.\nInvestors and economists are not expecting anything nearly as bold this week from either the ECB or BOJ.\nThe ECB is expected to be among the last to tighten policy, and the current unusually vibrant debate is focused on whether to dial back an exceptionally generous stimulus scheme just a notch. The caution is easy to understand. The bank has undershot its inflation target for most of the past decade, so it would rather move too late than too early, fearing that a misguided policy tweak could unravel years of work.\nThe euro zone's recovery is also trailing others. The bloc is just getting back to its pre-pandemic size and the job market could take another two years to recover. Debt levels are also at record highs, particularly in the bloc's south, so any big retreat could widen the spread between German and Italian debt, raising questions about the sustainability of these debt levels.\nGiven that the risk of moving too quick appears to far outweigh the risk of moving too slow, the ECB is likely to take only the smallest step towards removing extraordinary stimulus this week and will signal copious support, including thorough record low rates, at least through next year.\nIn Japan, the consumer-level inflation that is tearing through other parts of the globe remains largely absent. As such, only a marginal reduction in corporate asset purchases is under discussion at Friday's BOJ meeting.\nEven if the others are not hard on the Fed's heels, Powell and the Fed appear to have set the agenda for a tumultuous 2022 as central bankers chart their ways to the exits, albeit at dramatically different paces.\n\"You saw it in his congressional remarks that were more about tightening sooner than it was about worrying about the health of the global economy,\" said Vincent Reinhart, chief economist for Dreyfuss & Mellon. The Fed and other central banks are \"conveying a sense that they are heading for the exits. Modern central banking is much about managing expectations and they do not want to be seen as behind the curve.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604438959,"gmtCreate":1639437586879,"gmtModify":1639437587211,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"themes":[],"htmlText":"Go up pls","listText":"Go up pls","text":"Go up pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604438959","repostId":"2191984334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}